Also, our method could evaluate the HER2 copy number quantification within a tumor sample and assess more clear-cut heterogeneities of HER2, because HER2 gene copy numbers are present in each of those cancer cells within a tumor sample. This evidence concerns the gene ERBB2 and cancer.